Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Local complement activation in inflammatory bowel disease.

T S Halstensen1, P Brandtzaeg

  • 1Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), University of Oslo, National Hospital, Norway.

Immunologic Research
|January 1, 1991
PubMed
Summary

In ulcerative colitis, IgG1 autoantibodies activate complement, attacking the gut lining. Crohn's disease shows different complement patterns, possibly via the alternative pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of J chain in secretory immunoglobulin formation.

Scandinavian journal of immunology·2000
Same author

[Does reduced microbial exposure contribute to increased prevalence of allergy?].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2000
Same author

Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection.

Scandinavian journal of immunology·2000
Same author

Regulation of the formation and external transport of secretory immunoglobulins.

Critical reviews in immunology·2000
Same author

Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Clinical microbiology reviews·2000

Area of Science:

  • Immunology
  • Gastroenterology
  • Pathology

Background:

  • Inflammatory bowel disease (IBD) involves chronic gut inflammation.
  • Local complement activation is implicated in IBD pathogenesis.
  • Understanding complement's role can reveal therapeutic targets.

Purpose of the Study:

  • To investigate the localization and mechanisms of complement activation in ulcerative colitis and Crohn's disease.
  • To identify specific complement components and immunoglobulin subclasses involved in epithelial damage.

Main Methods:

  • Indirect two-colour immunofluorescence on mucosal biopsies.
  • Use of monoclonal antibodies against IgG subclasses, C3b, and terminal complement complex (TCC).
  • Combination with antisera to immunoglobulins and complement components.

Main Results:

  • Activated C3b and TCC deposits found on the epithelium in ulcerative colitis (91% and 81% of patients, respectively).
  • Selective deposition of immunoglobulin G subclass 1 (IgG1) in epithelial immune complexes in ulcerative colitis (63% of patients).
  • Epithelial complement deposition in Crohn's disease was granular, with no IgG co-localization, suggesting alternative pathway activation.

Conclusions:

  • IgG1 autoantibodies targeting brush-border antigens likely induce complement-mediated epithelial attack in ulcerative colitis.
  • Alternative complement pathway activation may drive epithelial damage in Crohn's disease.
  • Evidence suggests a Type III immune reaction with vascular complement activation in submucosal vessels in both diseases.

Related Experiment Videos